STOCK TITAN

AbbVie (ABBV) Total Assets by Year

ABBV NYSE

AbbVie Inc. closed fiscal year 2025 with $134.0B in total assets, $137.2B in total liabilities and -$3.3B in shareholder equity. Total assets fell 0.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters AbbVie Inc. has filed alongside them.

FY2025 annual
Total Assets $134.0B
Total Liabilities $137.2B
Total Equity -$3.3B
YoY -0.9%
5Y CAGR -2.3%
10Y CAGR +9.7%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ABBV Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY17FilingFY1610-QFY1510-QFY1410-KFY1310-KFY12FilingFY1110-K
Total Assets$134.0B-0.9%$135.2B+0.3%$134.7B-2.9%$138.8B-5.3%$146.5B-2.7%$150.6B+69.0%$89.1B+50.1%$59.4B-16.2%$70.8B+7.1%$66.1B+24.6%$53.0B+92.8%$27.5B-5.8%$29.2B+8.1%$27.0BN/A
Total Liabilities$137.2B+4.1%$131.8B+6.0%$124.4B+2.3%$121.6B-7.3%$131.1B-4.6%$137.5B+41.3%$97.3B+43.5%$67.8B+3.2%$65.7B+6.9%$61.5B+25.2%$49.1B+90.5%$25.8B+4.3%$24.7B-9.7%$27.4BN/A
Total Equity-$3.3B-198.3%$3.3B-67.9%$10.4B-40.0%$17.3B+12.0%$15.4B+17.8%$13.1Bn/m-$8.2Bn/m-$8.4B-265.7%$5.1B+9.9%$4.6B+17.5%$3.9B+126.5%$1.7B-61.2%$4.5Bn/m-$350.0MN/A

ABBV Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$147.7B+10.3%$135.1B-1.5%$136.5B+0.2%$134.0B-0.9%$133.9B-6.6%$137.2B-3.4%$136.2B-8.5%$135.2B+0.3%$143.4B+5.3%$141.9B+4.9%$148.9B+10.7%$134.7B-2.9%
Total Liabilities$152.3B+11.5%$141.1B+2.7%$143.1B+6.2%$137.2B+4.1%$136.5B-0.6%$137.4B+1.6%$134.7B-4.3%$131.8B+6.0%$137.4B+10.7%$135.2B+10.3%$140.9B+16.2%$124.4B+2.3%
Total Equity-$4.6Bn/m-$5.9Bn/m-$6.7B-568.7%-$3.3B-198.3%-$2.6B-143.8%-$183.0M-102.7%$1.4B-82.3%$3.3B-67.9%$6.0B-50.1%$6.8B-47.3%$8.0B-39.7%$10.4B-40.0%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More AbbVie Inc. financials

Frequently Asked Questions

AbbVie Inc. closed fiscal year 2025 with $134.0B in total assets, $137.2B in total liabilities and -$3.3B in shareholder equity.

AbbVie Inc. (ABBV) total assets fell by 0.9% year over year, from $135.2B to $134.0B in fiscal year 2025.

AbbVie Inc. (ABBV) reported $147.7B in total assets in Q3 2026. This represents an increase of 10.3% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what AbbVie Inc. (ABBV) reported on that line in every period on record.